Eli Lilly to Sell Weight Loss Drugs Directly to Patients

The platform offers access to Mounjaro and Zepbound by connecting patients with telehealth professionals for evaluation.
Eli Lilly to Sell Weight Loss Drugs Directly to Patients
Mohammed_Al_Ali/Shutterstock
|Updated:
0:00

Eli Lilly has launched a first-of-its-kind website, LillyDirect, that allows patients to access popular weight loss medications like Mounjaro and Zepbound more easily.

Through partnerships with telehealth providers, the platform enables medical evaluations and prescriptions. Once prescribed, the medications are then directly delivered to the patient’s home through affiliated pharmacy services.

A.C. Dahnke
A.C. Dahnke
Author
A.C. Dahnke is a freelance writer and editor residing in California. She has covered community journalism and health care news for nearly a decade, winning a California Newspaper Publishers Award for her work.
Related Topics